Integrated identification/confirmatory and targeted analysis of epoxyeicosatrienosic acids in human serum by LC-TOF MS and automated on-line SPE-LC-QqQ MS/MS.

A combined strategy is here proposed for qualitative/quantitative targeted analysis of epoxyeicosatrienoic acids (EETs) in human serum. Identification of EET regioisomers was initially carried out by LC-TOF MS in high accuracy mode under optimum conditions for chromatographic separation of the four isomers with an isocratic method using 40:40:20 (v/v/v) methanol-acetonitrile-water containing 0.02% acetic acid. Confirmatory analysis was supported on MS/MS experiments using the hybrid QqTOF mass analyzer by targeted fragmentation of the precursor ion fitting with the molecular formula C20H32O3 (319.2279 m/z). Identification of selective fragment ions in high accuracy mode enabled the localization of the epoxy functional group and, therefore, the assignation of chromatographic peaks to each EET isomer. After qualitative analysis, an automated method was developed for analysis of EETs in human serum by direct analysis using an on-line platform based on SPE-LC-QqQ MS/MS in selected reaction monitoring. Recovery factors estimated with a dual-cartridge configuration were above 87% for all metabolites either using non-spiked and spiked serum at three different concentrations. Precision, calculated as within-laboratory repeatability and expressed as relative standard deviation, ranged from 2.5 to 9.9% with detection limits below 0.15 ng mL(-1). The optimization of the method was completed with a stability study under different conditions to assess the suited conditions for analysis of EET intermediate metabolites. Finally, concentration ranges of EETs were measured in nine healthy individuals.

The elmiric acids: biologically active anandamide analogs.

As chemical entities, lipoamino acids have been known for some time. However, more recently their occurrence and importance in mammalian species has been discovered. They appear to have close relationships with the endocannabinoids not only structurally but also in terms of biological actions. The latter include analgesia, anti-inflammatory effects, inhibition of cell proliferation and calcium ion mobilization. To date about 40 naturally occurring members of this family have been identified and, additionally, several synthetic analogs have been prepared and studied. To facilitate their identity, a nomenclature system has been suggested based on the name elmiric acid (EMA). The prototypic example, N-arachidonoyl glycine, does not bind to CB1, however it does inhibit the glycine transporter GLYT2a and also appears to be a ligand for the orphan G-protein-coupled receptor GPR18. It may also have a role in regulating tissue levels of anandamide by virtue of its inhibitory effect on FAAH the enzyme that mediates inactivation of anandamide. Its concentration in rat brain is several-fold higher than anandamide supporting its possible role as a physiological mediator. Future studies should be aimed at elucidating the actions of all of the members of this interesting family of molecules.

International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor.

Oxoeicosanoids are a family of biologically active arachidonic acid derivatives that have been intimately linked with cellular migration. These metabolites are not only potent chemotaxins but also elicit oxygen radical production as well as induce secretory events in different cells. The most potent native ligand reported is 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE), and the cell membrane receptor activated has now been cloned. This receptor is distinct from those receptors activated by either the prostaglandins or the leukotrienes. The purpose of this review is to briefly summarize the molecular evidence and highlight the significance of this receptor. In addition, an official nomenclature for this oxoeicosanoid receptor is proposed.